The role of vascular endothelial growth factor in pediatric otitis media with effusion

Auris Nasus Larynx

Volumn 38, Issue 3, 2011, Pages 319-324

  Sekiyama, Kohsuke ^a   Ohori, Jun ichiro ^a   Matsune, Shoji ^a   Kurono, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Endotoxin; Middle ear effusion; Mucoid; Serous; VEGF

Indexed keywords

ALBUMIN; ENDOTOXIN; INTERLEUKIN 8; PHOSPHATE; SODIUM CHLORIDE; VASCULOTROPIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HUMAN; HUMAN TISSUE; IMPLANTATION; LIMULUS LYSATE TEST; MALE; MIDDLE EAR EFFUSION; MUCOSA; MYRINGOTOMY; ORGAN WEIGHT; OTITIS MEDIA; PATHOGENESIS; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SCHOOL CHILD; SEROSA; TYMPANOSTOMY TUBE; UPREGULATION;

CAPILLARY PERMEABILITY; CHILD; CHILD, PRESCHOOL; EAR, MIDDLE; ENDOTOXINS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INFANT; INTERLEUKIN-8; MALE; MIDDLE EAR VENTILATION; OTITIS MEDIA WITH EFFUSION; SERUM ALBUMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952736989     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2010.10.008     Document Type: Article

References (30)

1. Yellon R.F., Leonard G., Marucha P., Sidman J., Carpenter R., Burleson J., et al. Demonstration of interleukin 6 in middle ear effusions. Arch Otolaryngol Head Neck Surg 1992, 118:745-748.
2. Hotomi M., Samukawa T., Yamanaka N. Interleukin-8 in otitis media with effusion. Acta Otolaryngol 1994, 114:406-409.
3. Chae S.W., Kim S.J., Kim J.L., Jung H.H. Expression of vascular endothelial growth factor receptors in experimental otitis media in the rat. Acta Otolaryngol 2003, 123:559-563.
4. Jung H.H., Kim M.W., Lee J.H., Kim Y.T., Kim N.H., Chang B.A., et al. Expression of vascular endothelial growth factor in otitis media. Acta Otolaryngol 1999, 119:801-808.
5. Aoki K., Mitani Y., Tuji T., Hamada Y., Utahashi H., Moriyama H. Relationship between middle ear pressure, mucosal lesion, and mastoid pneumatization. Laryngoscope 1998, 108:1840-1845.
6. 2 levels in middle ear effusions and middle ear mucosa. Acta Otolaryngol Suppl 1990, 471:39-42.
7. Kim T.H., Chae S.W., Kim H.J., Jung H.H. Effect of recombinant vascular endothelial growth factor on experimental otitis media with effusion. Acta Otolaryngol 2005, 125:256-259.
8. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
9. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161:851-858.
10. Sun D., Matsune S., Ohori J., Fukuiwa T., Ushikai M., Kurono Y. TNF-alpha and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 2005, 32:243-249.
11. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
12. Yamanaka N., Somekawa Y., Suzuki T., Kataura A. Immunologic and cytologic studies in otitis media with effusion. Acta Otolaryngol (Stockh) 1987, 104:481-486.
13. Carrie S., Hutton D.A., Birchall J.P., Green G.G., Pearson J.P. Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol 1992, 112:504-511.
14. Chung M.H., Choi J.Y., Lee W.S., Kim H.N., Yoon J.H. Compositional difference in middle ear effusion: mucous versus serous. Laryngoscope 2002, 112:152-155.
15. Matsune S., Ohori J., Yoshifuku K., Kurono Y. Effect of vascular endothelial growth factor on nasal vascular permeability. Laryngoscope 2010, 120:844-848.
16. Ishii T., Toriyama M., Suzuki J.I. Histopathological study of otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1980, 89:83-86.
17. Iino Y. Eosinophilic otitis media: a new middle ear disease entity. Curr Allergy Asthma Rep 2008, 8:525-530.
18. Matsune S., Ohori J., Sun D., Yoshifuku K., Fukuiwa T., Kurono Y. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis. Am J Rhinol 2008, 22:365-370.
19. Berger G., Hawke M., Proops D.W., Ranadive N.S., Wong D. Histamine levels in middle ear effusions. Acta Otolaryngol 1984, 98:385-390.
20. Skoner D.P., Stillwagon P.K., Casselbrandt M.L., Tanner E.P., Doyle W.J., Fireman P. Inflammatory mediators in chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg 1988, 114:1131-1133.
21. Ogura M., Furukawa M., Tada N., Ikeda H., Yamashita T. Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. Auris Nasus Larynx 2008, 35:338-343.
22. Iino Y., Kaneko Y., Takasaka T. Endotoxin in middle ear effusions tested with Limulus assay. Acta Otolaryngol 1985, 100:42-50.
23. Smirnova M.G., Birchall J.P., Pearson J.P. In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol 2002, 122:146-152.
24. Kim Y.T., Jung H.H., Ko T.O., Kim S.J. Up-regulation of MUC5AC mRNA expression in endotoxin-induced otitis media. Acta Otolaryngol 2001, 121:364-370.
25. Takaki M., Ushikai M., Deguchi K., Nishimoto K., Matsune S., Kurono Y. The role of nuclear factor-kappa B in interleukin-8 expression by human adenoidal fibroblasts. Laryngoscope 2003, 113:1378-1385.
26. Leibovich S.J., Chen J.F., Pinhal-Enfield G., Belem P.C., Elson G., Rosania A., et al. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A (2A) receptor agonists and endotoxin. Am J Pathol 2002, 160:2231-2244.
27. DeMaria T.F., Murwin D.M. Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media. Laryngoscope 1997, 107:369-372.
28. Berse B., Hunt J.A., Diegel R.J., Morganelli P., Yeo K., Brown F., et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999, 115:176-182.
29. Crisostomo P.R., Wang Y., Markel T.A., Wang M., Lahm T., Meldrum D.R. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008, 294:675-682.
30. Hellwig-Bürgel T., Stiehl D.P., Wagner A.E., Metzen E., Jelkmann W. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 2005, 25:297-310.